Monalisa Mild + Lidocaine

Monalisa Mild Lidocaine is a premium, low-density cross-linked hyaluronic acid dermal filler developed by Genoss, engineered specifically for the correction of superficial facial lines, intermediate texture irregularities, and delicate soft tissue rejuvenation. Utilizing advanced Hy-Bi (Hybrid Biphasic) technology calibrated to its lowest extrusion profile, this medical-grade injectable features an ultra-fine, highly flexible uniform particle matrix. This specialized formulation delivers incredibly soft mechanical filling and high fluid distribution within highly active superficial planes, allowing the gel to blend seamlessly into delicate cutaneous layers without creating surface irregularities or lumps.

Formulated with integrated 0.3 percent lidocaine hydrochloride to reduce injection pressure and optimize patient comfort, Monalisa Mild is an exceptional precision backbar asset for targeting surface-level aging. It is explicitly indicated for superficial to mid-dermal placement to smooth fine perioral lines (smoker lines), soften early forehead creases, fill shallow glabellar lines, and refine delicate expression lines. The low-density, highly purified HA matrix undergoes meticulous washing to minimize residual chemical cross-linkers, ensuring excellent tissue bio-compatibility and a completely natural, unnoticeable feel that persists for 6 to 9 months.

Monalisa Mild Lidocaine provides aesthetic medical professionals with a highly predictable, fluid clinical asset designed to refine surface textures, restore subtle local hydration, and deliver delicate anti-aging correction to sensitive facial zones.

Key Benefits:

Low Density Particle Matrix: Specialized micro-particle engineering provides a lightweight, highly fluid gel consistency that ensures smooth extrusion and effortless intradermal placement.
Superficial Line Correction: Engineered to deliver soft, surface-level structural support to iron out shallow lines and fine dynamic wrinkles.
Integrated Local Anesthetic: Features 0.3 percent lidocaine hydrochloride to minimize patient discomfort and streamline multi-puncture clinical workflows.
Seamless Tissue Assimilation: Highly uniform gel network integrates flawlessly into superficial dermal layers with zero risk of the Tyndall effect or palpable nodules.
Dynamic Rejuvenation Preservation: Restores subtle skin volume and localized hydration while entirely maintaining the patient's natural, unhindered facial expressions.

Product Specifications and Packaging:

Volume: 1 x 1ml sterile, prefilled glass syringe.
Concentration: 20 mg/ml cross-linked sodium hyaluronate + 0.3 percent lidocaine hydrochloride.
Injection Depth: Superficial to mid-dermis.
Package Components: 1 x 1ml prefilled syringe, 2 x sterile 30G 1/2 needles.
Classification: CE marked medical device intended for professional clinical use only.

Usage:

For professional use only. Must be administered via superficial linear threading, serial puncture, or micro-papule techniques into the upper to mid-dermis by qualified, trained medical practitioners utilizing strict sterile clinical protocols.